Women's Health
FDA Approves Drospirenone Tablet for Pregnancy Prevention
FDA Approves Drospirenone Tablet for Pregnancy Prevention
A progestin-only pill, this estrogen-free oral contraceptive is intended as a 24 active and 4 inactive tablet dosing regimen.
Read More >>
Prescribing Contraceptives: Oregon Pharmacists Help the Medicaid Population
Multidisciplinary Approach Recommended for Management of Preexisting Diabetes in Pregnancy
Study: Racial Disparities Among Women with HIV
Hormone Therapy Combination Now Available for Treating Hot Flashes in Menopausal Women
New Treatment for Osteoporosis In Postmenopausal Women is Available
FDA Orders Safety Labeling Changes for Female Sexual Dysfunction Therapy
New Osteoporosis Therapy for Postmenopausal Women Granted FDA Approval
View more articles >>
Clinical Trials
Sexual Health Empowerment for Women's Health
Assessment of the Health Literacy Among Arab Women in East Jerusalem
Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women
Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls
Implementation Research for Vulnerable Women in South Africa